China’s Sinopharm Begins Part 3 Trial of COVID-19 Vaccine in Bahrain
DUBAI (Reuters) – Chinese language remark-owned pharmaceutical firm Sinopharm has begun Part III clinical trials of a COVID-19 vaccine in Bahrain, after launching the same trials in the United Arab Emirates closing month, Bahrain’s smartly being ministry talked about on…